IMAGE: Insights into MAnaging Growth for Endocrine nurses
The symposium was hosted by Springer Healthcare, in Prague, Czech Republic 9–10 October 2014
“A very welcoming atmosphere and …a really excellent meeting”
Martin O. Savage, Professor of Paediatric Endocrinology (Emeritus), William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, London, UK
The aims of the symposium were to provide quality education, based on practical clinical experience, on all aspects of the nurse’s role related to the management of the child receiving growth hormone therapy.
At the end of the symposium, delegates will understand:
- How to educate patients and families in the basic diagnosis and treatment of growth disorders
- The nurse’s role in taking responsibility for diagnostic techniques and therapy strategies
- Understanding the stresses of short stature and establishing trust with the patient and family
- How to monitor and manage patient progress, safety and adherence during therapy
Paediatric nurses and paediatric endocrine nurses.
This continuing education activity has been approved by the International Council of Nurses (ICN) for the award of 7.3 International Continuing Nursing Education Credits (ICNECs).
Springer Healthcare works in compliance with the principles of the Good CME Practice Group (gCMEp).
Message from the Chair
IMAGE Symposium – Prague, Czech Republic, 9–10 October 2014
Nurses are becoming increasingly involved and now play an important part in the care of patients with paediatric endocrinology disorders. In many centres, specialist nurses now take major responsibility for procedures related to the diagnosis and treatment of these disorders. Nurses with specialist training in this field have become integral to the efficient functioning of many hospital-based referral units, and both patients and medical staff are dependent on their contributions.
The Insights into MAnaging Growth for Endocrine nurses (IMAGE) Symposium, organised by Springer Healthcare, is an important opportunity for further training of nurses involved in paediatric endocrinology practice. The Faculty is headed by Kate Davies, Clinical Nurse Specialist in Paediatric Endocrinology at Great Ormond Street Hospital for Children in London, and nurses have key roles in the scientific programme.
The major theme of the symposium is related to the diagnosis and treatment of growth disorders. There will be plenary lectures, followed by generous time for discussion, and parallel break-out sessions dedicated to responses to growth hormone therapy in growth hormone deficiency, short stature related to birth weight small for gestational age, and Turner syndrome.
The plenary lectures will be given by both nurses and experienced clinical paediatric endocrinologists and will cover important topics such as the hormonal and genetic control of growth, the IGF-1 system, growth hormone resistance, licensed indications for growth hormone therapy, idiopathic short stature, the psychological stress of short stature and finally adherence to growth hormone therapy.
There will be an emphasis on informality, discussion and interchange of views and interaction between delegates and faculty. The IMAGE symposium offers an important opportunity for nurses to be updated on new developments in the growth field and to learn about the important opportunities that paediatric endocrinology can offer to nurses interested in becoming involved in this exciting branch of paediatrics.
Come to Prague for quality teaching, intellectual stimulation, and informal and practical exchange of views.
Day 0 – 8 October 2014
19:00 Welcome buffet and drinks reception
DAY ONE – 9 October 2014
09:00 – 09:10 Welcome, Introduction and Objectives of the Symposium Kate Davies
SESSION ONE: NORMAL AND ABNORMAL GROWTH
Chairs: Kate Davies and Martin Savage
09:10 – 09:30 Theoretical and practical aspects of anthropometric measurements Lee Martin
09:30 – 10:00 What is the IGF system and why is it important? Peter Bang
10:00 – 10:30 Genetic control of growth: Examples of abnormalities Marie-José Walenkamp
10:30 – 10:45 General discussion
10:45 – 11:15 COFFEE BREAK
SESSION TWO: HORMONE THERAPY FOR GROWTH
Chairs: Pauline Musson & Marie-José Walenkamp
11:15 – 11:45 GH and other hormone resistance states: Implications for growth Martin Savage
11:45 – 12:15 Are current indications for GH therapy justified? Pierre Chatelain
12:15 – 12:30 General discussion
12:30 – 13:30 LUNCH
SESSION THREE: PARALLEL BREAK-OUT GROUPS
Turner syndrome – Chairs: Pierre Chatelain & Nicole Kirouac
13:30 – 14:15 A patient with a good response to GH therapy – Why? Irena Hozjan
14:30 – 15:15 A patient with a poor response to GH therapy – Why? Rebecca Mayers
Summary by Chairs and Q & A
Small for gestational age – Chairs: Marie-José Walenkamp & John Chaplin
13:30 – 14:15 A patient with a good response to GH therapy – Why? Peter Laing
14:30 – 15:15 A patient with a poor response to GH therapy – Why? Lee Martin
Summary by Chairs and Q&A
15:15 – 15:40 COFFEE BREAK
SESSION FOUR: SHORT STATURE
Chair: Svante Norgren
15:40 – 16:10 A balanced view of idiopathic short stature management Martin Savage
16:10 – 16:30 Brief summary and key messages for the day Kate Davies
19:00 Conference dinner
DAY TWO – 10 October 2014
SESSION FIVE: TREATMENT OF GH DEFICIENCY
Chairs: Nicole Kirouac & Peter Bang
GH responses in GH deficiencyExamples and Explanations for good and poor responses to GH
09:30 – 09:50 Case Study: A good response to GH therapy – Why?Discussion Kate Davies
09:50 – 10:10 Case Study: A poor response to GH therapy – Why?Discussion Pauline Musson
10:10 – 10:40 Panel discussion on treatment of GH deficiencyPanel: Kate Davies, Pauline Musson, Marie-Jose Walenkamp, Pierre Chatelain
10:40 – 11:10 COFFEE BREAK
SESSION SIX: PSYCHOLOGICAL STRESS IN SHORT STATURE AND ADHERENCE TO GH THERAPY
Chairs: Kate Davies and Martin Savage
11:10 – 11:40 How stressful is short stature John Chaplin
11:40 – 12:10 Is poor adherence an issue in GH therapy? Svante Norgren
12:10 – 12:30 Panel discussion on the psychological pressures of short stature and their potential effects on adherence in GH therapy. Chairs: Kate Davies and Martin Savage
Panel members: John Chaplin, Svante Norgren, Irena Hozjan, Peter Laing
12:30 – 12:45 Summary of Symposium and Closing Remarks Martin Savage
12:45 MEETING CLOSE